Breast Cancer; HER2-positive; Metastatic

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB06366Pertuzumab3Recruiting1
DB00072Trastuzumab3Recruiting1
DB14962Trastuzumab deruxtecan3Recruiting1